NSYS
NEUTRALAt a glance
Key valuation, profitability, growth, and risk metrics.
AI Analysis
AI-powered fundamental assessment
Key Strengths
Key Risks
Performance Snowflake
Multi-dimensional analysis across 5 key categories
Valued primarily on assets and sales rather than earnings.
- P/S of 0.34 is significantly undervalued
- P/B of 1.18 is attractive
- Lack of earnings makes P/E and Graham Number unavailable
Growth rates are insufficient to justify a high-growth premium.
- Positive revenue growth
- Growth rate (5.9%) is anemic for the healthcare sector
- Negative profit margins
Price performance has been the primary driver of interest.
- Strong 1Y (+82.1%) and 6M (+46.3%) returns
- Consistent upward trend over 5 years
- Technical trend score (10/100) suggests a potential peak or reversal
Operational health is weak despite adequate short-term liquidity.
- Healthy Current and Quick ratios
- Piotroski F-Score of 2/9 is a major red flag
- Negative ROE
Non-dividend paying growth/recovery play.
- No dividend payments
- 0/100 dividend strength
Stock Price & Analyst Targets
Real-time price movements and analyst price targets
Multi-Horizon Performance vs Peers
Price momentum across 5Y → 1W horizons for NSYS and closest competitors.
| Company | 5Y | 3Y | 1Y | 6M | 1M | 1W |
|---|---|---|---|---|---|---|
|
NSYS
Nortech Systems Incorporated
Primary
|
+117.1% | +37.4% | +82.1% | +46.3% | +50.2% | +7.6% |
|
INCR
InterCure Ltd.
Peer
|
-91.7% | -67.4% | -37.5% | -52.3% | -4.7% | +0.4% |
|
APLM
Apollomics, Inc.
Peer
|
-98.0% | -98.1% | +148.8% | +191.4% | -0.5% | -0.8% |
|
BDMD
Baird Medical Investment Holdings Limited
Peer
|
-89.3% | -90.0% | -87.4% | -49.5% | -26.9% | -10.4% |
|
ATRA
Atara Biotherapeutics, Inc.
Peer
|
-98.9% | -95.6% | -24.7% | -54.9% | -70.3% | +15.0% |
Positive values indicate cumulative gains over the specified period. Comparables pulled from the same sector to highlight whether momentum is stock-specific or industry-wide.
Historical Performance Trends
Long-term financial metrics and growth patterns
Revenue & Net Income
Profit & Operating Margins
Return on Equity (ROE)
Quarterly Revenue Growth
Valuation Metrics
Key valuation ratios and pricing indicators
Profitability
Profit margins and return metrics
Growth
Revenue and earnings growth rates
Financial Health
Balance sheet strength and liquidity metrics
Financial Statement Flow
Interactive flow visualization showing how money moves through the company Q4 2025
Healthcare Sector Comparison
Similar Companies
Peer comparison within the same industry
| Company | AI Rating | Market Cap | P/E | ROE | Profit Margin | Price | |
|---|---|---|---|---|---|---|---|
|
NSYS
Nortech Systems Incorporated
|
NEUTRAL | $40.34M | - | -0.7% | -0.2% | $14.48 | |
|
INCR
InterCure Ltd.
|
BEARISH | $41.72M | - | -16.7% | -29.2% | $0.76 | Compare |
|
APLM
Apollomics, Inc.
|
BEARISH | $42.65M | - | -380.1% | -% | $19.9 | Compare |
|
BDMD
Baird Medical Investment...
|
BEARISH | $37.83M | - | -8.0% | -10.0% | $1.03 | Compare |
|
ATRA
Atara Biotherapeutics, Inc.
|
BEARISH | $37.64M | 1.83 | -% | 15.4% | $5.22 | Compare |
Past News Coverage
Recent headlines mentioning NSYS from our newsroom.